MTP 074 Clinical questions to be addressed: Is there a point when further drug additions are ineffective? Is the benefit of further reduction really worth the added morbidity of yet more medication? Are there ways to optimize the current regimen? Does drug-resistant high blood pressure need secondary hypertension work-up?